Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Palliat Med ; 19(12): 1320-1324, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27541289

RESUMO

BACKGROUND: Current methods for identifying patients at risk of dying within six months suffer from clinician biases resulting in underestimation of this risk. As a result, patients who are potentially eligible for hospice and palliative care services frequently do not benefit from these services until they are very close to the end of their lives. OBJECTIVE: To develop a prospective prognostic indicator based on actual survival within Centers for Medicare and Medicaid Services (CMS) claims data that identifies patients with congestive heart failure (CHF) who are at risk of six-month mortality. METHODS: CMS claims data from January 1, 2008 to June 30, 2009 were reviewed to find the first hospitalization for CHF patients with episode of care diagnosis-related groups (DRGs) 291, 292, and 293. Univariate and multivariable analyses were used to determine the associations between demographic and clinical factors and six-month mortality. The resulting model was evaluated for discrimination and calibration. RESULTS: The resulting prospective prognostic model demonstrated fair discrimination with an ROC of 0.71 and good calibration with a Hosmer-Lemshow statistic of 0.98. Across all DRGs, 5% of discharged patients had a six-month mortality risk of greater than 50%. CONCLUSION: This prospective approach appears to provide a method to identify patients with CHF who would potentially benefit from a clinical evaluation for referral to hospice care or for a palliative care consult due to high predicted risk of dying within 180 days after discharge from a hospital. This approach can provide a model to match at-risk patients with evidenced-based care in a more consistent manner. This method of identifying patients at risk needs further prospective evaluation to see if it has value for clinicians, increases referrals to hospice and palliative care services, and benefits patients and families.


Assuntos
Insuficiência Cardíaca , Cuidados Paliativos na Terminalidade da Vida , Hospitalização , Humanos , Cuidados Paliativos , Prognóstico , Estados Unidos
3.
Am J Med Qual ; 25(4): 297-304, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20606209

RESUMO

Airway management is germane to safe patient care. Keys to management of difficult airways (DAs) are the "Right People, Right Parts, and Right Place" (R3P3). Successful management of DA requires clinicians who have adequate training, experience, and equipment. Policies were implemented to optimize the management of DAs. One identified inpatients with potential DAs, whereas the other addressed creation and deployment of "Alpha Teams" (ATs). In the event of impending respiratory compromise, an AT was called in the same manner as a code blue. Health care providers were educated about these process changes, and ATs were tested using computerized patient simulators and self-paced observations. Testing assessed performance before, immediately after, and 30 days after the seminar. Changes in, and retention of, knowledge about DAs was analyzed. The goal of the R3P3 was to identify DAs and then to bring a well-trained hospital-wide AT to the bedside to decrease response time, rapidly establish a definitive airway, and improve survivability in an airway emergency.


Assuntos
Obstrução das Vias Respiratórias/terapia , Equipe de Respostas Rápidas de Hospitais/organização & administração , Hospitais , Humanos , Intubação Intratraqueal , Ohio , Estudos de Casos Organizacionais , Desenvolvimento de Programas , Avaliação de Programas e Projetos de Saúde , Literatura de Revisão como Assunto , Centros de Traumatologia
4.
Fam Med ; 35(1): 30-4, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12564861

RESUMO

The aging of the US population poses one of the greatest future challenges for family practice residency graduates. At a time when our discipline should be strengthening geriatric education to address the needs of our aging population, the Group on Geriatric Education of the Society of Teachers of Family Medicine believes that recent guidelines from important family medicine organizations suggest that our discipline's interest in geriatric education may be waning. Barriers to improving geriatric education in family practice residencies include limited geriatric faculty, changes in geriatric fellowship training, competing curricular demands, and limited diversity of geriatric training sites. Improving geriatric education in family practice residencies will require greater emphasis on faculty development and integration of geriatric principles throughout family practice residency education. The Residency Review Committee for Family Practice should review the Program Requirements for Residency Education to ensure that geriatric training requirements are consistent with current educational needs. The leadership of family medicine organizations should collaboratively address the need for continued improvement in training our residents to care for older patients and the chronically ill.


Assuntos
Competência Clínica , Currículo , Medicina de Família e Comunidade/educação , Geriatria/educação , Avaliação das Necessidades/tendências , Dinâmica Populacional , Idoso , Idoso de 80 Anos ou mais , Avaliação Educacional , Feminino , Humanos , Internato e Residência/organização & administração , Relações Interprofissionais , Masculino , Qualidade da Assistência à Saúde , Estados Unidos
5.
Am Fam Physician ; 66(2): 273-80, 2002 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-12152963

RESUMO

Since their introduction in the late 1980s, proton pump inhibitors have demonstrated gastric acid suppression superior to that of histamine H2-receptor blockers. Proton pump inhibitors have enabled improved treatment of various acid-peptic disorders, including gastroesophageal reflux disease, peptic ulcer disease, and nonsteroidal antiinflammatory drug-induced gastropathy. Proton pump inhibitors have minimal side effects and few significant drug interactions, and they are generally considered safe for long-term treatment. The proton pump inhibitors omeprazole, lansoprazole, rabeprazole, and the recently approved esomeprazole appear to have similar efficacy.


Assuntos
Refluxo Gastroesofágico/tratamento farmacológico , Omeprazol/análogos & derivados , Inibidores da Bomba de Prótons , 2-Piridinilmetilsulfinilbenzimidazóis , Benzimidazóis/farmacocinética , Benzimidazóis/farmacologia , Benzimidazóis/uso terapêutico , Interações Medicamentosas , Esomeprazol , Humanos , Lansoprazol , Omeprazol/farmacocinética , Omeprazol/farmacologia , Omeprazol/uso terapêutico , Pantoprazol , Úlcera Péptica/tratamento farmacológico , Rabeprazol , Sulfóxidos/farmacocinética , Sulfóxidos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA